Also, CDK7’s role in overcoming chemotherapeutic resistance in breast cancer was mentioned before, where CDK7 inhibition by TZH1 was found to reverse the resistant in HER2+ breast cancer patients [37]. This evidence concerns the gene ERBB2 and breast carcinoma.